Power Michel Mikhail - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Reporting relationship: Chief Regulatory Officer
Issuer ticker: N/A
Reported as of: 15 Nov 2021
Net transaction value: +$75
SEC form: 4
Accepted by SEC: 02 Dec 2021, 15:08:57 UTC
Prior SEC filing: 05 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Erika L. Eves for Michel Mikhail, by power of attorney

Key filing fact

Power Michel Mikhail filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 02 Dec 2021.

Key facts

This page summarizes Power Michel Mikhail's Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Dec 2021, 15:08.

Change

Previous filing in this sequence was filed on 05 Oct 2021.
Current net transaction value: +$75.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NAVB transaction Derivative

Stock Option

Award

Transaction value: $75
Shares: +75,000
Change %
Price: $0.001000^*
Shares after: 75,000
Date: 15 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price: $1.37
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.